1 |
Diclofenac |
Plasma |
K2 EDTA |
Xevo TQD |
5 to 2000 |
ng/mL |
2 |
Indomethacin |
Plasma |
K2 EDTA |
Xevo TQD |
20 to 6000 |
ng/mL |
3 |
Oxcarbazepine & MHD |
Plasma |
K2 EDTA |
Xevo TQD |
10 to 4000, 40 to 16000 |
ng/mL |
4 |
Etravirine |
Plasma |
K2 EDTA |
Xevo TQD |
5 to 1500 |
ng/mL |
5 |
Carglumic acid |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
80 to 6000 |
ng/mL |
6 |
Acyclovir |
Plasma |
K2 EDTA |
Xevo TQD |
5 to 2000 |
ng/mL |
7 |
Atovaquone |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
50 to 2000 |
ng/mL |
8 |
Levonorgestrel |
Plasma |
K2 EDTA |
Xevo TQ XS |
0.2 to 50 |
ng/mL |
9 |
Rifabutin |
Plasma |
K2 EDTA |
Xevo TQD |
2 to 600 |
ng/mL |
10 |
Hydroxychloroquine |
Whole Blood |
K2 EDTA |
Xevo TQD |
2 to 700 |
ng/mL |
11 |
Flucytosin |
Plasma |
K2 EDTA |
Xevo TQD |
0.05 to 25 |
µg/mL |
12 |
Metolazone |
Plasma |
K2 EDTA |
Xevo TQD |
0.5 to 250 |
ng/mL |
13 |
Erythromycin |
Plasma |
K2 EDTA |
Xevo TQD |
10 to 2000 |
ng/mL |
14 |
Pregabalin |
Plasma |
K2 EDTA |
Xevo TQD |
100 to 18000 |
ng/mL |
15 |
Levetiracetam |
Plasma |
K2 EDTA |
Xevo TQD |
0.5 to 100 |
µg/mL |
16 |
Erythromycin Ethyl Succinate |
Plasma |
K2 EDTA |
Xevo TQD |
10 to 2000 |
ng/mL |
17 |
Chlorzoxazone |
Plasma |
K2 EDTA |
Xevo TQD |
0.5 to 80 |
µg/mL |
18 |
Clarithromycin |
Plasma |
K2 EDTA |
Xevo TQD |
25 to 3200 |
ng/mL |
19 |
Chlorpromazine/7-hydroxy chlorpromazine |
Plasma |
K2 EDTA |
Xevo TQD |
0.5 to 100/ 0.75 to 150 |
ng/mL |
20 |
Acetazolamide |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
0.5 to 30 |
µg/mL |
21 |
Methsuximide/Normethsuximide |
Plasma |
K2 EDTA |
Xevo TQD |
60 to 6000 |
ng/mL |
22 |
Digoxin |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
80 to 6000 |
pg/mL |
23 |
Celecoxib |
Plasma |
K2 EDTA |
Xevo TQD |
30 to 2700 |
ng/mL |
24 |
Enatacopone |
Plasma |
K2 EDTA |
Xevo TQD |
20 to 4200 |
ng/mL |
25 |
Sulfamethoxazole & Trimethoprim |
Plasma |
K2 EDTA |
Xevo TQD |
320-22000/ 10-700 |
ng/mL |
26 |
Amlodipine |
Plasma |
K2 EDTA |
Xevo TQD |
50 to15600 |
pg/mL |
27 |
Carbamazepine & Carbamazepine-10, 11- epoxide |
Plasma |
K2 EDTA |
Xevo TQD |
40 to 4000, 2 to 200 |
ng/mL |
28 |
Naproxen |
Plasma |
K2 EDTA |
Xevo TQD |
1 to 200 |
µg/mL |
29 |
Fludrocortisone |
Plasma |
K2 EDTA |
Xevo TQ XS |
40 to 2400 |
pg/mL |
30 |
Fluphenazine |
Plasma |
K2 EDTA |
Xevo TQ XS |
40 to 5000 |
pg/mL |
31 |
Gabapentine |
Plasma |
K2 EDTA |
Xevo TQD |
100 to 18000 |
ng/mL |
32 |
Methyltestosterone |
Plasma |
K2 EDTA |
Xevo TQ XS |
500 to 25000 |
pg/mL |
33 |
Paroxetine |
Plasma |
K2 EDTA |
Xevo TQD |
0.35 to 40 |
ng/mL |
34 |
Dichlorphenamide |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
15 to 1500 |
ng/mL |
35 |
Fluvoxamine |
Plasma |
K2 EDTA |
Xevo TQD |
2 to 150 |
ng/mL |
36 |
Tacrolimus |
Whole Blood |
K2 EDTA |
Xevo TQD |
0.2 to 60 |
ng/mL |
37 |
Sipronolactone |
Plasma |
K2 EDTA |
Xevo TQD |
5 to 400 |
ng/mL |
38 |
Oxandralone |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
5 to 400 |
ng/mL |
39 |
Famoditine |
Plasma |
K2 EDTA |
Xevo TQD |
4 to 300 |
ng/mL |
40 |
Ethosuximide |
Plasma |
K2 EDTA |
Xevo TQS |
150 to 12000 |
ng/mL |
41 |
Diltiazem and its metabolite |
Plasma |
K2 EDTA |
Xevo TQD |
5/1.5/0.5-350/100/40 |
ng/mL |
42 |
Mexiletine |
Plasma |
K2 EDTA |
Xevo TQD |
10 to 1000 |
ng/mL |
43 |
Tranexamic acid |
Plasma |
K2 EDTA |
Xevo TQD |
150 to 15000 |
ng/mL |
44 |
Bisoprolol and Hydrochlorothiazide |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
1 to 100 |
ng/mL |
45 |
Tadalafil |
Plasma |
K2 EDTA |
Xevo TQD |
10 to 1200 |
ng/mL |
46 |
Sildenafil and N-desmethyl sildenafil |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
5 to 1000/ 2 to 400 |
ng/mL |
47 |
Misoprostol Acid |
Plasma |
K2 EDTA |
Xevo TQ XS |
3 to 500 |
pg/mL |
48 |
Phenoxybenzamine |
Plasma |
K2 EDTA |
Xevo TQ XS |
50 to 5000 |
pg/mL |
49 |
Mesalamine |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
40 to 3000 |
ng/mL |
50 |
Atenolol |
Plasma |
K2 EDTA |
Xevo TQD |
15 to 1200 |
ng/mL |
51 |
Chlorthalidone |
Plasma |
K2 EDTA |
Xevo TQD |
50 to 3000 |
ng/mL |
52 |
Misoprostol Acid |
Plasma |
K2 EDTA |
Xevo TQ XS |
10 to 1300 |
pg/mL |
53 |
Bisoprolol |
Plasma |
K2 EDTA |
Xevo TQD |
1 to 100 |
ng/mL |
54 |
Dexamethasone |
Plasma |
K2 EDTA |
Xevo TQD |
1 to 100 |
ng/mL |
55 |
Amlodipine |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
75 to 6000 |
pg/mL |
56 |
Hydrochlorthiazide |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
5 to 500 |
ng/mL |
57 |
Estradiol |
Plasma |
K2 EDTA |
Xevo TQ XS |
3 to 150 |
pg/mL |
58 |
Glipizide |
Plasma |
K2 EDTA |
Xevo TQD |
20 to 2000 |
ng/mL |
59 |
Ursodiol and its metabolites |
Plasma |
K2 EDTA/ K3 EDTA |
Xevo TQ XS/ Xevo TQ S |
75/6.5/75 to 8000/700/8000 |
ng/mL |
60 |
Levocarnitine |
Plasma |
K2 EDTA |
Xevo TQD |
0.1 to 22 |
µg/mL |
61 |
Perindopril |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
0.5 to 50 |
ng/mL |
62 |
Nitrofurantoin |
Plasma |
K2 EDTA |
Xevo TQS |
5 to 500 |
ng/mL |
63 |
Isotretinoin |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
0.99 to 1200 |
ng/mL |
64 |
Nordiazepam |
Plasma |
K2 EDTA |
Xevo TQS |
5 to 700 |
ng/mL |
65 |
Alprazolam |
Plasma |
K2 EDTA |
Xevo TQS |
0.035 to 35 |
ng/mL |
66 |
Prochlorperazine |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
40 to 3000 |
pg/mL |
67 |
Oxazepam |
Plasma |
K2 EDTA |
Xevo TQD |
20 to 1500 |
ng/mL |
68 |
Trimethoprim |
Plasma |
K2 EDTA |
Xevo TQD |
30 to 2000 |
ng/mL |
69 |
Tiopronine |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
100 to 15000 |
ng/mL |
70 |
Guanfacine |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
0.05 to 5 |
ng/mL |
71 |
Unconjugated Estrone+ Estradiol |
Plasma |
K2 EDTA |
Xevo TQ XS |
5-500/10-1000 |
pg/mL |
72 |
Total Estrone |
Plasma |
K2 EDTA |
Xevo TQ XS |
0.1 to 50 |
ng/mL |
73 |
S-Methyl Diethyldithiocarbamate |
Plasma |
K2 EDTA |
Xevo TQS |
0.5 to 50 |
ng/mL |
74 |
Tizanidine |
Plasma |
K2 EDTA |
Xevo TQS |
0.1 to 10 |
ng/mL |
75 |
21-Desacetyl Deflazacort |
Plasma |
K2 EDTA |
Xevo TQD |
3 to 450 |
ng/mL |
76 |
Furosemide |
Plasma |
K2 EDTA |
Xevo TQD |
0.05 to 10 |
µg/mL |
77 |
Hydrocortisone |
Plasma |
K2 EDTA |
Xevo TQD |
10 to 700 |
ng/mL |
78 |
Loratadine |
Plasma |
K2 EDTA |
Xevo TQS |
0.1 to 10 |
ng/mL |
79 |
Ursodiol and its metabolites |
Plasma |
K2 EDTA |
Xevo TQ XS |
75/6.5/75 to 8000/700/8000 |
ng/mL |
80 |
Chlorpromazine/7-hydroxy chlorpromazine |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
0.25/0.10 to 25/10 |
ng/mL |
81 |
Tafamadis |
Plasma |
K2 EDTA |
Xevo TQD |
0.035 to 10 |
µg/mL |
82 |
Theophylline |
Plasma |
K2 EDTA |
Xevo TQD |
0.25 to 25 |
µg/mL |
83 |
Dutasteride |
Plasma |
K2 EDTA |
Xevo TQS |
80 to 6000 |
pg/mL |
84 |
Ibuprofen |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
0.5 to 40 |
µg/mL |
85 |
Fluphenazine |
Plasma |
K2 EDTA |
Xevo TQS |
2.5 to 1000 |
pg/mL |
86 |
Ketoprofen |
Plasma |
K2 EDTA |
Xevo TQD |
0.25 to 15 |
µg/mL |
87 |
Megestrol Acetate |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
2 to 200 |
ng/mL |
88 |
Trientine |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
5 to 1200 |
ng/mL |
89 |
Indomethacin |
Plasma |
K2 EDTA |
Xevo TQD |
20 to 25000 |
ng/mL |
90 |
Carbinoxamine |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
0.5 to 50 |
ng/mL |
91 |
Nortriptyline |
Plasma |
K2 EDTA |
Xevo TQD |
0.5 to 50 |
ng/mL |
92 |
Methyl prednisolone |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
10 to 700 |
ng/mL |
93 |
Omeprazole |
Plasma |
K2 EDTA |
Xevo TQD |
4 to 600 |
ng/mL |
94 |
Hydralazine |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
1-100 |
ng/mL |
95 |
Terazosin |
Plasma |
K2 EDTA |
Xevo TQD |
0.2-50 |
ng/mL |
96 |
Finasteride and Tadalafil |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
1-100/2.5-250 |
ng/mL |
97 |
Ivermectin |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
0.25 to 60 |
ng/mL |
98 |
Cetirizine |
Plasma |
K2 EDTA |
Xevo TQD |
5 - 800 |
ng/mL |
99 |
Tolvaptan |
Plasma |
K2 EDTA |
Xevo TQD |
5 to 1000 |
ng/mL |
100 |
Esmoperazole |
Plasma |
K2 EDTA |
Xevo TQD |
10 to 5000 |
ng/mL |
101 |
Dexamethasone (20mg) |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
4 to 600 |
ng/mL |
102 |
Prucalopride |
Plasma |
K2 EDTA |
Xevo TQD |
0.1 to 20 |
ng/mL |
103 |
Perampanel |
Plasma |
K2 EDTA |
Xevo TQD |
5 to 750 |
ng/mL |
104 |
Estradiol |
Plasma |
K2 EDTA |
Xevo TQ XS |
1 to 150 |
pg/mL |
105 |
Viladagliptin & Metformin |
Plasma |
K2 EDTA |
Xevo TQD |
4to 600/30 to 4500 |
ng/mL |
106 |
Pentoxifylline and its metabolites |
Plasma |
K2 EDTA |
Xevo TQXS |
3.5 to 350/7.5 to 750/15 to 1500 |
ng/mL |
107 |
Viladagliptin |
Plasma |
K2 EDTA |
Xevo TQD |
4 to 600 |
ng/mL |
108 |
Probenecid |
Plasma |
K2 EDTA |
Xevo TQD |
2 to 140 |
µg/mL |
109 |
Testosterone |
Serum |
K2 EDTA |
Xevo TQXS |
0.1 to 20 |
ng/mL |
110 |
Pitolisant |
Serum |
K2 EDTA |
Xevo TQS |
0.1 to 50 |
ng/mL |
111 |
Dienogest |
Plasma |
K2 EDTA |
Xevo TQS |
1 to 200 |
ng/mL |
112 |
Trientine and its metabolite |
Plasma |
K2 EDTA |
Xevo TQD |
35 to 7000/15 to 3000 |
ng/mL |
113 |
Cyclosporine |
Plasma |
K2 EDTA |
Xevo TQD |
10 to 1200 |
ng/mL |
114 |
Levoketaconazole |
Plasma |
K2 EDTA |
Xevo TQD |
0.1 to 10 |
µg/mL |
115 |
Valproic acid |
Plasma |
K2 EDTA |
Xevo TQD |
0.25 to 25 |
µg/mL |
116 |
Rivaroxaban |
Plasma |
K2 EDTA |
Xevo TQXS |
2 to 600 |
ng/mL |
117 |
Progesterone |
Plasma |
K2 EDTA |
Xevo TQXS |
0.1 to 150 |
ng/mL |
118 |
Mebendazole |
Plasma |
K2 EDTA |
Xevo TQXS |
0.3 to 150 |
ng/mL |
119 |
6-Methoxy-2-Naphthyl acetic acid (Produg Nabumetone) |
Plasma |
K2 EDTA |
Xevo TQD |
0.1 to 10 |
µg/mL |
120 |
Everolimus |
Whole Blood |
K2 EDTA |
Xevo TQ-S micro |
0.2 to 100 |
ng/mL |
121 |
Maraviroc |
Plasma |
K2 EDTA |
Xevo TQD |
10 to 1500 |
ng/mL |
122 |
Empagliflozin |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
5 to 800 |
ng/mL |
123 |
6-Methoxy-2-Naphthyl acetic acid (Produg Nabumetone) |
Plasma |
K2 EDTA |
Xevo TQD |
0.5 to 50 |
µg/mL |
124 |
Ketoconazole |
Plasma |
K2 EDTA |
Xevo TQD |
0.1 to 10 |
µg/mL |
125 |
Metronidazole and Tetracycline |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
200 to 20000/ 15 to 1500 |
ng/mL |
126 |
Clopidogrel |
Plasma |
K2 EDTA |
Xevo TQS |
25 to 5000 |
pg/mL |
127 |
Omeprazole |
Plasma |
K2 EDTA |
Xevo TQD |
40 to 3000 |
ng/mL |
128 |
Bismuth |
Plasma |
K2 EDTA |
7850 ICPMS |
0.1 to 50 |
ng/mL |
129 |
Memantine and Donepzil |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
0.75 to 75/ 0.4 to 40 |
ng/mL |
130 |
Bempedoic acid & its metabolite |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
250- 25000/40-4000 |
ng/mL |
131 |
Rabeprazole |
Plasma |
K2 EDTA |
Xevo TQ-S micro/ TQS |
5 to 1200 |
ng/mL |
132 |
Ibuprofen |
Plasma |
K2 EDTA |
Xevo TQXS |
5 to 500 |
ng/mL |
133 |
Ketoprofen |
Plasma |
K2 EDTA |
Xevo TQS |
0.5 to 100 |
ng/mL |
134 |
Efavirenz |
Plasma |
K2 EDTA |
Xevo TQS |
50 to 5000 |
ng/mL |
135 |
Ticagrelor |
Plasma |
K2 EDTA |
Xevo TQS |
10 to 1100 |
ng/mL |
136 |
Sitagliptin |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
5 to 1000 |
ng/mL |
137 |
Metformin |
Plasma |
K2 EDTA |
Xevo TQD |
20 to 4000 |
ng/mL |
138 |
Solifenacin |
Plasma |
K2 EDTA |
Xevo TQS |
0.1 to 30 |
ng/mL |
139 |
Rosuvastatin |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
0.3 to 75 |
ng/mL |
140 |
Semaglutide |
Plasma |
K2 EDTA |
Xevo TQXS |
1 to 500 |
ng/mL |
141 |
Posaconazole |
Plasma |
K2 EDTA |
Xevo TQ S |
10 to 2000 |
ng/mL |
142 |
Liraglutide |
Plasma |
K2 EDTA |
Xevo TQXS |
0.5 to 200 |
ng/mL |
143 |
Zotepine |
Plasma |
K2 EDTA |
Xevo TQ-S micro/ TQS |
0.2 to 40 |
ng/mL |
144 |
Zuclomiphene & Enclomiphene |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
0.15/0.1 to 22.5/15 |
ng/mL |
145 |
Pimozide |
Plasma |
K2 EDTA |
Xevo TQXS |
25 to 5000 |
pg/mL |
146 |
Verapamil and its metabolite |
Plasma |
K2 EDTA |
Xevo TQS |
0.25/0.25 to 300/300 |
ng/mL |
147 |
Clindamycin |
Plasma |
K2 EDTA |
Xevo TQD |
0.075 to 10.5 |
µg/mL |
148 |
Methenamine |
Plasma |
K2 EDTA |
Xevo TQ-S micro |
0.5 to 80 |
ng/mL |
149 |
Free Propranolol and 4-Hydroxypropranolol |
Plasma |
K2 EDTA |
Xevo TQXS |
0.5/0.5 to 75/75 |
ng/mL |
150 |
Total Propranolol and 4-Hydroxypropranolol |
Plasma |
K2 EDTA |
Xevo TQXS |
0.5/0.5 to 250/250 |
ng/mL |
151 |
Mesna |
Plasma |
K2 EDTA |
Xevo TQD |
1 to 100 |
µg/mL |